March 16, 2017 / 3:57 PM / a year ago

BUZZ-U.S. STOCKS ON THE MOVE-Oracle, Canada Goose, PTC Therapeutics

* Eikon search string for individual stock moves: STXBZ

* The Day Ahead newsletter:

* The Morning News Call newsletter:

U.S. stocks slipped on Thursday as declines in the healthcare sector outweighed gains in financial stocks.

The Dow Jones Industrial Average was down 0.19 percent at 20,909.65, the S&P 500 was down 0.28 percent at 2,378.68 and the Nasdaq Composite was down 0.19 percent at 5,889.003.

** ORACLE CORP, $46.13, +7.15 pct

The business software maker reported better-than-expected quarterly profit and adjusted revenue as the business software maker benefited from its transition to cloud-based products.

** GOPRO INC, $8.45, +14.97 pct

The wearable device maker on Wednesday estimated its first-quarter revenue at the top end of its previous forecast, and said it would cut about 270 jobs as it tries to reduce expenses in a bid to turn a profit in 2017.

** BIOGEN INC, $276.14, -5.64 pct

Brokerages Morgan Stanley and Leerink downgraded the drugmaker’s stock and price targets.

** CANADA GOOSE HOLDINGS INC, $16.46, +28.80 pct

The maker of C$900 parkas made a strong market debut on Thursday after raising C$340 million ($256 million) in an initial public offering.

** TESLA INC, $264.17, +3.30 pct

The electric carmaker said it expected to raise about $1.15 billion from stock and senior notes offering as it accelerated the launch of its new Model 3 electric sedan.

** PTC THERAPEUTICS INC, $9.64, -11.56 pct

The drug developer said it would buy Marathon Pharmaceuticals LLC’s recently-approved Duchenne muscular dystrophy drug, Emflaza, and promised to re-examine the hefty U.S. price tag on the treatment.

** DOLLAR GENERAL CORP, $74.68, +2.57 pct

The U.S. discount retailer reported a 13.7 percent increase in quarterly sales as strong demand for home products pushed up sales at its stores.

** INOVIO PHARMACEUTICALS INC, $6.14, -10.63 pct

Brokerage Piper Jaffray downgraded the vaccine developer’s stock to “neutral” from “overweight”.

** EDITAS MEDICINE INC, $25.88, +5.03 pct

The gene-editing company will sell 4 million shares in a public offering to fund preclinical studies and clinical trials for its drug programs that treat inherited eye disorders.

** GALENA BIOPHARMA INC, $0.66, +13.27 pct

The drug developer is evaluating strategic alternatives, including a sale.

** GUESS INC, $10.90, -10.87 pct

The apparel retailer posted lower-than-expected fourth-quarter profit and revenue due to weakness in Americas retail segment.

** INTREPID POTASH INC, $1.31, -8.10 pct

The potash producer offered 43.5 million shares for gross raise of nearly $52.3 million to partially repay outstanding senior note debt and for general corporate purposes.

** CATO CORP, $21.38, -6.96 pct

The women’s apparel and accessories retailer reported a 12 percent drop in sales.

** KCG HOLDINGS INC, $18.05, +6.80 pct

** VIRTU FIANCIAL INC, $16.10, -3.88 pct

Virtu has made a bid to buy rival trading firm KCG Holdings to bolster its businesses that have softened under reduced market volatility.

** B&G FOODS INC, $39.05, -7.13 pct

The snack food company said its Chief Financial Officer Thomas Crimmins resigned.

** PATHEON NV, $26.43, -15.80 pct

The drug developer reported quarterly results that missed analysts’ expectations and gave a disappointing outlook for 2017.


The property and casualty insurer posted narrower-than-expected fourth-quarter loss, but revenue fell short of estimates. (Compiled by Akankshita Mukhopadhyay in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below